phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Apnea

phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Apnea in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Andrzejewski, K; Kaczyńska, K; Wojciechowski, P	1

Other Studies

1 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Apnea

Article	Year
Intracerebroventricular Neuropeptide FF Diminishes the Number of Apneas and Cardiovascular Effects Produced by Opioid Receptors' Activation. International journal of molecular sciences, 2020, Nov-25, Volume: 21, Issue:23 Topics: Analgesia; Analgesics, Opioid; Animals; Apnea; Cardiovascular Diseases; Disease Models, Animal; Humans; Infusions, Intraventricular; Oligopeptides; Pain Perception; Rats; Receptors, Neuropeptide; Receptors, Opioid, mu; Transcriptional Activation	2020

Article

Year

Intracerebroventricular Neuropeptide FF Diminishes the Number of Apneas and Cardiovascular Effects Produced by Opioid Receptors' Activation.

International journal of molecular sciences, 2020, Nov-25, Volume: 21, Issue:23

Topics: Analgesia; Analgesics, Opioid; Animals; Apnea; Cardiovascular Diseases; Disease Models, Animal; Humans; Infusions, Intraventricular; Oligopeptides; Pain Perception; Rats; Receptors, Neuropeptide; Receptors, Opioid, mu; Transcriptional Activation

2020